This article is more than 5 years old. Information may no longer be current.

STAAR Surgical reports 10% increase in Q2 revenue

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

STAAR Surgical reported a 10% increase in revenue for the second quarter of 2014, from $18.2 million to $20 million, according to a company press release.

Revenues grew 11% on a constant currency basis during the second quarter of 2014 compared with the same period last year, according to the release. Foreign currency exchange reduced sales by $0.1 million during the quarter.

These results included quarterly sales of $12.2 million of STAAR’s Visian ICL product portfolio, and $6.4 million of its IOL products, according to the press release.

Other product sales were $1.4 million, representing a 39% increase compared with the second quarter of last year.

The company’s GAAP net loss was $1.8 million, or $0.05 on a per diluted share basis for the second quarter of 2014, compared with a net income of $278,000, or $0.01 on a per diluted share basis in the second quarter of last year, according to the press release.

STAAR expects second-half growth rates to increase as a result of new product releases and increase IOL supply, the release said.